PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Szczech LA et al. – The increased risks associated with higher hemoglobin targets are not clinically apparent among subgroups with greater mortality risk. These differential outcomes underscore the need for dedicated trials in these subpopulations.

Related Articles

Iron-Refractory Iron Deficiency Anemia
Seminars in Hematology, 10/05/09    Relevance Score: 94%

Fanconi Anemia Complementation Group FANCD2 Protein Serine 331 Phosphorylation Is Important for Fanconi Anemia Pathway Function and BRCA2 Interaction
Cancer Research, 11/17/09    Relevance Score: 91%

A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/14/09    Relevance Score: 91%

Prevalence and pathogenesis of anemia in Inflammatory Bowel disease. Influence of anti-tumor necrosis factor-alpha treatment
Haematologica, 10/12/09    Relevance Score: 91%

Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment
Seminars in Hematology, 10/05/09    Relevance Score: 91%

Today in Hematology/Oncology...keeping you current

Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis
Cancer Causes and Control, 11/25/09

Hemorrhagic Gastritis and Duodenitis Following Celiac Plexus Neurolysis
Pain Physician, 11/25/09

Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer
Archives of Otolaryngology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address